DHL Expands Investment Focus on Healthcare and Life Sciences Logistics

On 5 November 2026, DHL Group highlighted healthcare and life sciences among its priority growth areas and planned higher investment in logistics infrastructure. The company forecast 2026 capital expenditure of approximately €3.6 billion, compared with its previous range of €3 billion to €3.3 billion, while expecting operating profit above €7 billion. Healthcare logistics providers, pharmaceutical distributors and cold-chain technology companies can explore opportunities as medical supply networks expand. HPC can support healthcare supplier sourcing, logistics partnerships and connections with international service providers.